Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02687659
Other study ID # 2014-A00444-43
Secondary ID
Status Completed
Phase N/A
First received May 31, 2014
Last updated February 19, 2016
Start date May 2014
Est. completion date January 2015

Study information

Verified date February 2016
Source University Hospital, Angers
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

Physical inactivity is a major public health issue. Prescription of physical activity appears necessary in some situation with cardiovascular risk. It is important to both qualify and quantify daily physical activity.

The aim of this project is to evaluate the TEMIS system (based on a smart T-shirt) performance in 12 healthy subjects, wearing this system over the daytime during one week.


Description:

Healthy subjects have to make different physical activities, wearing the TEMIS system like slow and fast walking, biking, running.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date January 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Men or women 18 - 50 yo

- BMI between 18 and 30

- Without chronic disease or chronic treatment (oral contraception is allowed)

- Normal electrocardiogram

- Able to do all the specified physical activity requested by the protocol

- Able to use smart phone and computers

- With access to WIFI, bicycle, and car

- Living in the close area

- Affiliated to public health insurance

Exclusion Criteria:

- Severe allergia

- Severe skin lesions at the thorax level

- Not able to use correctly the TEMIS system

- Will take plane during the week of evaluation

- Under protection

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
TEMIS system
Wearing TEMIS system over the day during one week

Locations

Country Name City State
France CHU Angers Angers Maine et Loire

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Angers MEDES Institut de Médecine et de Physiologie Spatiales, Toulouse, University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary concordance (kappa score) between actual and estimated physical activity Investigators will during the seven days of the protocol, when the system TEMIS is hold, evaluate the concordance between the activity really performed by the subject (questionnaire) and the activity calculated by the TEMIS System (Kappa test). Investigators will evaluate the following activity:
lying position, sitting position, standing position, walking activity, running activity, bicycle activity, use of a vehicle (car, bus)
One week (average of each day recording) No
Secondary total duration of recording in hours One week (sum of each day recording) No
Secondary number of subjects with adverse events will be considered as adverse events
allergia
discomfort with removal of the system
one week Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links